Sage Therapeutics, Inc.

BANK OF AMERICA CORP /DE/

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

145,799

Value ($000)

1,330

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	1,330	0.0%	145,799	6/30/2025
2025 Q1	5/15/2025	1,622	0.0%	203,997	3/31/2025
2024 Q4	2/14/2025	1,720	0.0%	316,673	12/31/2024
2024 Q3	11/14/2024	4,851	0.0%	671,950	9/30/2024
2024 Q2	8/14/2024	5,548	0.0%	510,881	6/30/2024
2024 Q1	5/15/2024	9,831	0.0%	524,595	3/31/2024
2023 Q4	2/14/2024	5,841	0.0%	269,551	12/31/2023
2023 Q3	11/14/2023	10,220	0.0%	496,593	9/30/2023
2023 Q2	8/14/2023	6,392	0.0%	135,944	6/30/2023
2023 Q1	5/12/2023	11,917	0.0%	284,001	3/31/2023
2022 Q4	2/10/2023	9,429	0.0%	247,211	12/31/2022
2022 Q3	11/14/2022	7,645	0.0%	195,216	9/30/2022
2022 Q2	8/12/2022	5,036	0.0%	155,921	6/30/2022
2022 Q1	5/16/2022	7,980	0.0%	241,088	3/31/2022
2021 Q4	2/8/2022	6,044	0.0%	142,092	12/31/2021
2021 Q3	11/15/2021	3,602	0.0%	81,302	9/30/2021
2021 Q2	9/13/2021	6,103	0.0%	107,439	6/30/2021
2021 Q1	5/14/2021	6,537	0.0%	87,329	3/31/2021
2020 Q4	2/10/2021	9,268	0.0%	107,131	12/31/2020
2020 Q3	11/13/2020	5,018	0.0%	82,107	9/30/2020
2020 Q2	8/14/2020	6,166	0.0%	148,300	6/30/2020
2020 Q1	5/15/2020	5,460	0.0%	190,128	3/31/2020
2019 Q4	2/14/2020	13,523	0.0%	187,322	12/31/2019